Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos

Endocrinology

Volumn 143, Issue 10, 2002, Pages 4038-4047

  Demiralp, Burak ^a   Chen, Hen L I ^b   Koh, Amy J ^c   Keller, Evan T ^d   McCauley, Laurie K ^a,c  

^a Department of Periodontics/Prevention/Geriatrics ^*  (United States)

^b Unit for Laboratory Animal Medicine   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE GROWTH; CALCIUM TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HORMONAL REGULATION; MEDIATOR RELEASE; MINERALIZATION; MOUSE; MULTIGENE FAMILY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR BINDING; TRABECULAR BONE;

ANABOLIC AGENTS; ANIMALS; BONE DEVELOPMENT; CALCIUM; EXTRACELLULAR MATRIX PROTEINS; FEMUR; GROWTH PLATE; MICE; MICE, KNOCKOUT; MINERALS; ORGAN SIZE; OSTEOCALCIN; PARATHYROID HORMONE; PROTO-ONCOGENE PROTEINS C-FOS; SKULL; SPINE;

EID: 0036772573     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220221     Document Type: Article

References (50)

1. Hock JM, Fitzpatrick LA, Bilezikian JP 2002 Actions of parathyroid hormone. In: Principles of Bone Biology. 2nd ed. San Diego: Academic Press; 463-482
2. Tam CS, Heersche JN, Murray TM, Parsons JA 1982 Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110:506-512
3. Rixon RH, Whitfield JF, Gagnon L, Isaacs RJ, Maclean S, Chakravarthy B, Durkin JP, Neugebauer W, Ross V, Sung W, Willick GE 1994 Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 9:1179-1189
4. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446
5. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant H, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Eng J Med 10:1434-1441
6. Rihani-Bisharat S, Maor G, Lewinson D 1998 In vivo anabolic effects of parathyroid hormone (PTH) 28-48 and N-terminal fragments of PTH and PTH-related protein on neonatal mouse bones. Endocrinology 139:974-981
7. Miyakoshi N, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S 2001 Evidence that anabolic effects of PTH on bone require IGF-1 in growing mice. Endocrinology 142:4349-4356
8. Miao D, He B, Karaplis AC, Goltzman D 2002 Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109:1173-1182
9. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, Mulligan RC 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289
10. Lee K, Deeds JD, Chiba S, Un-No M, Bond AT, Segre GV 1994 parathyroid hormone induces sequential c-fos expression in bone cells in vivo: In situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 134:441-450
11. McCauley LK, Koh AJ, Beecher CA, Rosol TJ 1997 The proto-oncogene c-fos is transcriptionally regulated by PTH and PTHrP in a cAMP-dependent manner in osteoblastic cells. Endocrinology 138:5427-5433
12. Finkel MP, Biskis BO, Jinkins PB 1966 Virus induction of osteosarcomas in mice. Science 151:698-701
13. Grigoriadis AE, Wang ZQ, Wagner EF 1995 Fos and bone cell development: Lessons from a nuclear oncogene. Trends Genet 11:436-441
14. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF 1992 Bone and haematopoietic defects in mice lacking c-fos. Nature 360: 741-745
15. Sabatakos G, Sims NA, Chen K, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R 2000 Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6:985-990
16. Jochum W, David JP, Elliott C, Wutz A, Plenk H, Matsuo K, Wagner EF 2000 Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6:980-984
17. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF 2000 Fos/1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 24:184-187
18. Dony C, Gruss P 1987 Proto-oncogene c-fos expession in growth regions of fetal bone and mesodermal web tissue. Nature 328:711-714
19. Wang ZQ, Grigoriadis AE, Mohle-Steinlein U, Wagner EF 1991 A novel target cell for c-fos induced oncogenesis: Development of chrondrogenic tumours in embryonic stem cell chimeras. EMBO J 10:2437-2450
20. Johnson RS, Spiegelman BM, Papaioannou V 1992 Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577-586
21. Gröne A, McCauley LK, Capen CC, Rosol TJ 1997 PTH/PTHrP receptor expression in humoral hypercalcemia of malignancy in nude mice with the canine apocrine adenocarcinoma (CAC-8). J Endocrinol 153:123-129
22. McCauley LK, Koh-Paige AJ, Chen H, Chen C, Ontiveros C, Irwin R, McCabe LR 2001 Parathyroid hormone stimulates fra-2 expression in osteoblastic cells in vitro and in vivo. Endocrinology 142:1975-1981
23. McCauley LK, Beecher CA, Melton ME, Werkmeister JR, Jüppner H, Abou-Samra AB, Segre GV, Rosol TJ 1994 Transforming growth factor β regulates steady state PTH/PTHrP receptor mRNA levels and PTHrP binding in ROS 17/2.8 osteosarcoma cells. Mol Cell Endocrinol 101:331-336
24. Celeste AJ, Rosen V, Bueker JL, Kriz R, Wang EA, Wozney JM 1986 Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 5:1885-1890
25. Young MF, Ibaraki K, Kerr JM, Lyu MS, Kozak CA 1994 Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression, and genetic mapping. Mammalian Genome 5:108-111
26. Abou-Samra AB, Jüppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT, Kronenberg HM, Segre GV 1992 Expression cloning of a common receptor for parathryoid hormone and parathryoid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphophates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732-2736
27. Elima K, Metsaranta M, Kallio J, Perala M, Eerola I, Garofalo S, de Crombrugghe B, Vuorio E 1992 Specific hybridization probes for mouse α2(IX) and α1(X) collagen mRNAs. Biochim Biophys Acta 1130:78-80
28. Dai J, Lin D, Zhang J, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET 2000 Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest 106:887-895
29. McCauley LK, Rosol TJ, Capen CC, Horton JE 1989 A comparison of bone turnover in athymic (nude) and euthymic mice: Biochemical, histomorphometric, bone ash and in vitro studies. Bone 10:29-34
30. Zhao W, Byrne MH, Wang Y, Krane SM 2000 Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest 106:941-949
31. Mohan S, Kutilek S, Zhang C, Shen HG, Kodma Y, Srivastava AK, Wergedal JE, Beamer WG, Baylink DJ 2000 Comparison of bone formation responses to parathyroid hormone (1-34), (1-31) and (2-34) in mice. Bone 27:471-478
32. Iida-Klein A, Zhou H, Shou Lu S, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R 2002 Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 17:808-816
33. Koh AJ, Beecher CA, Rosol TJ, McCauley LK 1999 3′, 5′-Cyclic adenosine monophosphate activation in osteoblastic cells: Effects of parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Endocrinology 140:3154-3162
34. Gopalakrishnan R, Ouyang H, Somerman MJ, McCauley LK, Franceschi RT 2001 Matrix Gla protein is a key regulator of PTH-mediated inhibition of mineralization in osteoblasts. Endocrinology 142:4379-4388
35. Manolagas SC 2000 Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
36. Lee K, Lanske B, Karaplis AC, Deeds JD, Kohno H, Nissenson RA, Kronenberg HM, Segre GV 1996 Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 137:5109-5118
37. Ganss B, Kim RH, Sodek J 1999 Bone sialoprotein. Crit Rev Oral Biol Med 10:79-98
38. Chen J, Shapiro HS, Sodek J 1992 Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7:987-997
39. Robey PG 2002 Bone matrix proteoglycans and glycoproteins. In: Principles of Bone Biology. 2nd ed. San Diego: Academic Press; 225-238
40. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM 1999 Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 104:399-407
41. Lian JB, Stein GS, Stein JL, Van Wijnen AJ 1998 Osteocalcin gene promoter: Unlocking the secrets for regulation of osteoblast growth and differentiation. J Cell Biochem 31(Suppl):62-72
42. Weir EC, Philbrick WM, Amling M, Neff L, Baron R, Broadus AE 1996 Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 93:10240-10245
43. Schipani E, Langman C, Hunzelman J, Le Merrer M, Loke Y, Dillon MJ, Silve C, Jüppner H 1999 A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. J Clin Endocrinol Metab 84:3052-3057
44. Schipani E, Kruse K, Jüppner H 1995 A constitutively active mutant PTH/ PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268: 98-100
45. Schipani E, Lanske B, Hunzelman J, Luz A, Kovacs CS, Lee K, Pirro A, Kronenberg H, Jüppner H 1997 Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci USA 94:13689-13694
46. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ 1996 Regulation of rate of cartilage differentiation by indian hedgehog and PTH-related protein. Science 273:613-622
47. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Jüppner H, Segre GV, Kronenberg HM 1996 PTH/PTHrP receptor in early development and indian hedgehog-regulated bone growth. Science 273:663-666
48. Lanske B, Divieti P, Kovacs CS, Pirro A, Landis WJ, Krane SM, Bringhurst FR, Kronenberg HM 1998 The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology 139:5194-5204
49. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM 1996 Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122:3151-3162
50. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z 1998 MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422